Response to Letter to Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”

ElsevierVolume 26, Issue 12, December 2020, Pages e335-e336Biology of Blood and Marrow TransplantationAuthor links open overlay panelOlalekan O. Oluwole 1, Jeroen P. Jansen 2, Vincent W. Lin 3, Keith Chan 4, Sam Keeping 4, Lynn Navale 3, Frederick L. Locke 5Show morePrevious article in issueNext article in issue

Recommended articles

Financial disclosure: See Acknowledgments on page e336.

© 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.

View original article
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comments (0)

No login
gif
format_indent_decrease